- What is the current operational status of POCARED Diagnostics?
- POCARED Diagnostics is currently inactive and ceased to operate in February 2025.
- What is POCARED Diagnostics' primary focus?
- POCARED Diagnostics is an in vitro diagnostics company developing a microbiology platform for automated, reagent-free microorganism detection.
- What is the total amount of funding POCARED Diagnostics has raised?
- POCARED Diagnostics has raised a total of $103,380,000.
- When did POCARED Diagnostics secure its most recent funding round and who was the lead investor?
- POCARED Diagnostics secured its most recent funding round in May 2022, with the European Investment Bank (EIB) as the lead investor.
- Which investors participated in POCARED Diagnostics' July 2021 funding round?
- The July 2021 funding round for POCARED Diagnostics was led by.
- What is the employee count for POCARED Diagnostics?
- POCARED Diagnostics has 1-10 employees.
- Who are the co-founders of POCARED Diagnostics?
- The co-founders of POCARED Diagnostics are Jonathan Gurfinkel, who also serves as President, CEO & Board member, and Gal Ingber, who is the VP R&D.
- What technology does POCARED Diagnostics' P-1000 system utilize for microorganism detection?
- POCARED Diagnostics' P-1000 system uses intrinsic fluorescence, optical data analysis, and artificial intelligence methods to analyze the multidimensional optical characteristics of microorganisms.